Cargando…
Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening
Hereditary tyrosinemia type 1 (HT1) is a rare autosomal recessive disorder of phenylalanine and tyrosine catabolism due to a deficiency of fumarylacetoacetate hydrolase. HT1 has a large clinical spectrum with acute forms presenting before six months of age, subacute forms with initial symptoms occur...
Autores principales: | Hajji, Hela, Imbard, Apolline, Spraul, Anne, Taibi, Ludmia, Barbier, Valérie, Habes, Dalila, Brassier, Anaïs, Arnoux, Jean-Baptiste, Bouchereau, Juliette, Pichard, Samia, Sissaoui, Samira, Lacaille, Florence, Girard, Muriel, Debray, Dominique, de Lonlay, Pascale, Schiff, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649935/ https://www.ncbi.nlm.nih.gov/pubmed/36393896 http://dx.doi.org/10.1016/j.ymgmr.2022.100933 |
Ejemplares similares
-
Citrulline in the management of patients with urea cycle disorders
por: Imbard, Apolline, et al.
Publicado: (2023) -
Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up
por: Demaret, Tanguy, et al.
Publicado: (2021) -
Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening
por: Bower, Alexandra, et al.
Publicado: (2019) -
Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort
por: Wicker, Camille, et al.
Publicado: (2020) -
Administration of gamma‐hydroxybutyrate instead of beta‐hydroxybutyrate to a liver transplant recipient suffering from propionic acidemia and cardiomyopathy: A case report on a medication prescribing error
por: Tuchmann‐Durand, Caroline, et al.
Publicado: (2020)